Valrubicin: A Viewpoint by N. Aydain Mungan

ISSN： 1170-229X

Source： Drugs & Aging, Vol.15, Iss.1, 1999-07, pp. : 76-76

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Valrubicin

By Onrust S.V. Lamb H.M.

Drugs & Aging, Vol. 15, Iss. 1, 1999-07 ,pp. : 69-75

Adis International

Access to resources Recommend Favorite

Intravesical valrubicin for bladder cancer

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 268, 2000-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Febuxostat: A Viewpoint by N. Lawrence Edwards

By Edwards N. Lawrence

Drugs, Vol. 68, Iss. 13, 2008-01 ,pp. : 1875-1876

Adis International

Access to resources Recommend Favorite

Zolpidem Extended-Release: A Viewpoint by David N. Neubauer

By Neubauer David N.

CNS Drugs, Vol. 20, Iss. 5, 2006-01 ,pp. : 428-428

Adis International

Access to resources Recommend Favorite

Intravesical valrubicin in the treatment of carcinoma in situ of the bladder

By Steinberg GD Kuznetsov DD O’Connor RC Alsikafi NF

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 6, 2001-06 ,pp. : 1009-1013

Informa Healthcare

Access to resources Recommend Favorite